Back to search

United Kingdom· GB-APID-15051211000001106

Amiloride 5mg / Bumetanide 1mg tablets

A medicinal product containing amiloride + bumetanide, registered in United Kingdom by Essential Generics Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedAmiloride 5mg / Bumetanide 1mg tabletsATC—REGISTER NO.GB-APID-1505121100000…PACKS LISTED2CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Amiloride + Bumetanide
Manufacturer
Essential Generics Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    5050204100759
  • gtin
    05050204100759

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3029cbdc-7657-43f0-bc40-4504c5c3eaf9
GET /v1/drugs/3029cbdc-7657-43f0-bc40-4504c5c3eaf9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "15051211000001106",
  "desc": "Amiloride 5mg / Bumetanide 1mg tablets (Essential Generics Ltd)",
  "form": "Oral tablet",
  "vpid": "42290711000001106",
  "source": "dmd",
  "vtm_id": "774537007",
  "strength": "1 mg",
  "substance": "Amiloride + Bumetanide",
  "ingredient": "Bumetanide",
  "supplier_code": "9477011000001107"
}

See everything about amiloride + bumetanide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.